[Ambulatory long-term prevention of XXXX with low-molecular weight heparin].

@entity1 @entity1031 @entity548
@entity1 with severe @entity548 complications and other side effects on conventional anticoagulants and strong indication for further anticoagulation were treated with a low molecular weight heparin fragment (Tedelparin). In this paper we report the experiences in 30 @entity1 , who were anticoagulated 1-11 months with this compound. All @entity1 injected themselves a dose ranging from 1 X 2,500 to 1 X 20,000 anti factor Xa units per day. Within 132 months of treatment one @entity1 with good compliance developed @entity1031 . Four @entity1 had bad compliance. Two of them experienced rethrombosis 1 and 8 weeks after starting therapy. Severe @entity548 did not occur. Two @entity1 had one minor @entity548 complication each. Both @entity1 developed several times per year severe @entity548 with conventional anticoagulants. All excessive subcutaneous haematomas and indurations of the adipose tissue at the injection site of conventional heparin disappeared completely. Low molecular weight heparin can be regarded as an alternative anticoagulant in @entity1 with severe @entity548 and other complications on oral anticoagulants and conventional heparin.
